News

Bausch + Lomb has concluded its acquisition of a portion of the assets and intellectual property for Miochol(R)-E from affiliates of Novartis AG. The business intends to complete the acquisition of the remaining assets and intellectual property upon the necessary regulatory clearance.

Although near vision can never be assessed objectively, standardization between tests would be useful. However, as Dr Oliver Findl demonstrated, there is a lack of standardization between tests so that comparison of results of different near vision tests is difficult, or not possible.

Clear lens extraction can be offered to ametropic patients in their presbyopic age as a refractive procedure that can virtually eliminate any need for optical correction.

Bausch + Lomb and Croma-Pharma presented a symposium exploring some of the opportunities and challenges associated with the management of a patient with postoperative inflammation in cataract surgery.

From the first clinical use of a photodisruptive laser (pico second) for vitreous lysis to more than 1800 systems now installed worldwide and three and a half million surgeries having been conducted Dr Joseph Colin talks us through how far things have come.